Bruker Corporation
Financials
Valuation Metrics
Bruker Corporation's Market Cap is $9.80B. At end of 2025 it was $7.16B. Ranked #961 of 3,112 in US market (top 31%), #309 of 1,445 on NASDAQ (top 21%), #65 of 206 in Health Care Equipment & Services (top 32%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $9.80B | US#961/3,112 Sec#65/206 |
| Revenue | $3.46B | US#1,132/3,112 Sec#64/206 |
| Net Income | $-12M | US—/3,112 Sec—/206 |
| Total Assets | $6.13B | US#1,294/3,112 Sec#59/206 |
| Net Assets | $2.45B | US#1,119/3,112 Sec#58/206 |
| Employees | 11,085 | US#560/3,112 Sec#51/206 |
| Value | ||
| P/B | 4.00x | US#1,978/3,112 Sec#123/206 |
| P/S | 2.83x | US#1,675/3,112 Sec#118/206 |
| EV/EBITDA | 37.45x | US#2,270/3,112 Sec#121/206 |
| FCF Yield | 0.52% | US#2,189/3,112 Sec#136/206 |
| Profitability | ||
| ROE | -0.47% | US#2,172/3,112 Sec#113/206 |
| ROA | -0.19% | US#2,227/3,112 Sec#116/206 |
| Op. Margin | 5.89% | US#1,980/3,112 Sec#100/206 |
| Revenue Growth | 2.75% | US#1,971/3,112 Sec#144/206 |
| Earnings Growth | -17.24% | US#1,628/3,112 Sec#82/206 |
| Financial Health | ||
| Debt Ratio | 148.13% | US#1,485/3,112 Sec#137/206 |
| Total Debt | $1.67B | US#1,231/3,112 Sec#61/206 |
| FCF | $51M | US#1,923/3,112 Sec#118/206 |
| Cash | $133M | US#2,022/3,112 Sec#127/206 |
| Current Ratio | 1.55x | US#1,611/3,112 Sec#144/206 |
| Net Debt/EBITDA | 5.08x | US#2,060/3,112 Sec#128/206 |
| Dividend | ||
| Div. Yield | 0.33% | US#1,572/3,112 Sec#47/206 |
| Div. Growth | -25.90% | US—/3,112 Sec—/206 |
| Performance | ||
| 1Y Return | 69.88% | US#382/3,112 Sec#34/206 |
| 1M Return | 4.43% | US#1,016/3,112 Sec#80/206 |
| From 52W High | -1.42% | US#144/3,112 Sec#5/206 |
| 1Y MDD | -39.85% | US#1,945/3,112 Sec#109/206 |
| Trading | ||
| Volume | 2,144,634 shares | US#844/3,112 Sec#53/206 |
| Trading Value | $136M | US#715/3,112 Sec#57/206 |
| Per Share | ||
| EPS | $-0.06 | US—/3,112 Sec—/206 |
| BPS | $16.16 | US#1,409/3,112 Sec#82/206 |
Company Info
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.